MedCity News
DECEMBER 3, 2024
When you combine clean data with longitudinal patient records and transparent access — that’s when you start seeing real transformation in care delivery. The post Set the Data Free: Break the Chains of Information Silos appeared first on MedCity News.
Fierce Pharma
DECEMBER 3, 2024
Over the last two-plus years, as Eli Lilly and Novo Nordisk have battled for their share of the massive weight loss market and patients wondered which company’s products were more effective, there | Eli Lilly revealed results from a study that showed its obesity drug Zepbound was 47% more effective than Novo’s Wegovy in helping patients lose weight.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Impetus Digital
DECEMBER 23, 2024
Pharma-exclusive Webinar: The 2025 Pharma Toolkit for Virtual Medical Education About the webinar Step into the future of medical education with our exclusive webinar series from February 25-26, designed specifically for Pharma leaders. This transformative series will showcase the 2025 Pharma Toolkit for Virtual Medical Education, revealing groundbreaking virtual tools and strategies set to revolutionize how we engage and educate HCPs, patients, and teams.
PharmaVoice
DECEMBER 17, 2024
Bluejay Therapeutics is one of just a handful of companies developing treatments for hepatitis D.
Advertiser: ZoomInfo
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
Referral MD
DECEMBER 9, 2024
Prior authorization is a pivotal component of healthcare, bridging the relationship between patients, healthcare providers, and insurance companies. While it can seem complex and frustrating, prior authorization is vital in balancing quality care and cost efficiency. This blog outlines the essentials of prior authorization what it is, why it exists, the steps involved, and how the process can be improved.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
DECEMBER 22, 2024
Dexcom recently became the first medical device company to embed generative AI into a continuous glucose monitor. Adding generative AI to the companys Stelo glucose monitor will give users more personalized recommendations about how to improve their metabolic health, said Dexcom COO Jake Leach. The post Dexcom Adds Generative AI Platform to Its Over-the-Counter CGM appeared first on MedCity News.
Fierce Pharma
DECEMBER 17, 2024
Its not a new question, but it is one that is gaining increased traction: Is there a link between Novo Nordisks diabetes superstar Ozempic and blindness? | After the recent release of two independent studies from the University of Southern Denmark suggested the use of Ozempic increases patients' chances of developing a rare eye disorder, the Danish Medicines Agency has asked European officials to investigate.
Integrity Solutions
DECEMBER 13, 2024
From predictive analytics and sales automation to chat bots and conversational intelligence, more businesses are taking advantage of the latest advances in artificial intelligence (AI) and automation capabilities. It’s a trend that will only accelerate over the next few years. Digital technologies and AI tools have much to offer in terms of improving sales efficiencies, personalizing content, providing more data-driven insights and automating the tedious tasks that have frustrated salespeo
PharmaVoice
DECEMBER 4, 2024
Dr. Marty Makary’s conflicts of interest could come into question before he is confirmed as the next FDA commissioner.
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
Healthcare Success
DECEMBER 2, 2024
Your value proposition is more than just a catchy phrase —it’s a vital tool that piques interest, communicates your brand identity, and compels consumers to book an appointment. And, it can increase patient volume and revenue. Here’s why: Your value proposition is, at its foundation, an essential component of your brand messaging. A quick primer: Your Tagline A concise, memorable statement that explains what your organization stands for.
Pharma Marketing Network
DECEMBER 31, 2024
Table of Contents Sr# Headings 1 Introduction: The Pharma Marketing Challenge 2 Building a Winning Pharma Marketing Strategy 3 The Role of Branded Drug Campaigns 4 Innovating for Future Success Introduction: The Pharma Marketing Challenge Marketing pharmaceuticals is no small feat. In an industry where lives are at stake, creating compelling, compliant, and effective campaigns can feel like walking a tightrope.
MedCity News
DECEMBER 30, 2024
One Phase 3 test of Auvelity met its main goal in Alzheimers agitation while the drugs other pivotal trial showed numerical improvement that fell short of statistical significance. Axsome Therapeutics aims to offer an alternative to Rexulti, a Lundbeck and Otsuka Pharmaceutical product that is the only FDA-approved Alzheimers agitation drug. The post Axsome Aims for FDA Filing in Alzheimers Agitation Despite Mixed Bag of Phase 3 Data appeared first on MedCity News.
Fierce Pharma
DECEMBER 4, 2024
AstraZeneca’s Daiichi Sankyo-partnered antibody-drug conjugate Enhertu has made it onto China’s national insurance program despite the star med being a part of an ongoing investigation in the count | AstraZeneca’s Daiichi Sankyo-partnered antibody-drug conjugate Enhertu has made it onto China’s national insurance program despite the star med being a part of an ongoing investigation in the country.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Contrarian Sales Techniques
DECEMBER 3, 2024
So, you’re thinking about starting a career in pharmaceutical sales ? Great choice. It’s not just another job—it’s a chance to build a career where you can grow, earn well, and genuinely make a difference. With Malaysia’s healthcare industry expanding rapidly, companies are always on the lookout for talented people who can help bring their products to the market.
PharmaVoice
DECEMBER 13, 2024
Amid the DEI backlash in corporate America, pharma leaders are quietly adjusting tactics.
European Pharmaceutical Review
DECEMBER 3, 2024
Novartis Pharmaceuticals Corporation (a subsidiary of Novartis AG), is set to collaborate with PTC Therapeutics to develop the potential first oral disease-modifying therapy for Huntington’s disease. The global license and collaboration agreement is focused on PTC Therapeutics’ PTC518 Huntington’s disease programme. PTC will receive $1.0 billion upfront.
PM360
DECEMBER 20, 2024
In the high-stakes world of healthcare, the relationship between pharmaceutical advertising and the people it aims to reach is at a critical crossroads. For far too long, underserved communities have seen little in these ads that speak to their lives let alone their unique healthcare journeys. Now more than ever, the industry is recognizing that diversity, equity, and inclusion (DEI) are not just add-ons, but essential elements that define successful, meaningful campaigns.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
MedCity News
DECEMBER 10, 2024
Arcellxs cell therapy for multiple myeloma has shown no signs of the parkinsonism complication observed in clinical testing of Carvykti, a rival product from partners Johnson & Johnon and Legend Biotech. Arcellx is developing its CAR T-treatment under a partnership with Gilead Sciences. The post Safety Stands Out in Arcellx Cell Therapys ASH Data, But Dont Overlook Manufacturing Advantages appeared first on MedCity News.
Fierce Pharma
DECEMBER 19, 2024
The FDA has doubled down on its decision to remove Eli Lillys tirzepatide from its list of products that are in shortage. | The FDA has doubled down on its decision to remove Eli Lillys tirzepatide from its list of products that are in shortage. The agencys move means that compounding pharmacies will have to halt production of their knockoff versions of diabetes drug Mounjaro and obesity treatment Zepbound.
Contrarian Sales Techniques
DECEMBER 8, 2024
Whats it really like to work as a medical sales rep for a multinational pharmaceutical company (MNC) in Malaysia? From early morning territory visits to evening follow-ups, its a fast-paced, rewarding career with its fair share of challenges and surprises. If youve ever wondered what goes on behind the scenes, heres a glimpse into a typical day in the life of a medical sales rep in an MNChighlighting the perks, obstacles, and realities of the job. 6:30 AM: Starting the Day Right A medical sales
PharmaVoice
DECEMBER 19, 2024
A new antibody from Merck would join a market teeming with new entries, but plenty of regulatory and financial uncertainty.
European Pharmaceutical Review
DECEMBER 2, 2024
This report delves into the latest developments in sustainability impacting the pharmaceutical sector today. Inside, articles explore current key topics including regulation, manufacturing, green chemistry, digitalisation and clinical trials. Stay up to date with the latest developments in sustainability including articles on: The key regulatory frameworks impacting the pharmaceutical industry and the challenges and opportunities around their implementation How digitalisation can transform and
Pharma Marketing Network
DECEMBER 4, 2024
Table of Contents Sr# Headings 1 Introduction 2 Digital Transformation in Pharma Marketing 3 Patient-Centric Marketing 4 Personalized Healthcare Campaigns 5 The Role of AI and Machine Learning 6 Leveraging Social Media Platforms 7 Data-Driven Decision Making 8 Omnichannel Marketing Strategies 9 The Power of Influencer Marketing 10 Navigating Regulatory Challenges 11 Sustainability in Pharma Marketing 12 Conclusion 13 FAQs Introduction Pharma marketing is undergoing a revolution.
MedCity News
DECEMBER 5, 2024
The startup’s first disease target is chronic inflammatory demyelinating polyneuropathy (CIDP), which can be treated with a blockbuster Argenx drug. Nuvig aims to show its drug can offer a better way to treat this disease and other autoimmune conditions. The post Nuvig Therapeutics Nabs $161M to Build Case for a Better Approach to Autoimmune Disease appeared first on MedCity News.
Fierce Pharma
DECEMBER 2, 2024
The FDA is investigating reports of patients develo | The FDA is investigating reports of patients developing blood cancer after receiving bluebird bio’s gene therapy Skysona and is evaluating the need for “further regulatory action,” the U.S. agency said last week. The FDA notification came seven weeks after the New England Journal of Medicine (NEJM) published a report that seven of 67 children who received Skysona during clinical trials had developed blood cancer.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Contrarian Sales Techniques
DECEMBER 9, 2024
When people think of medical sales, they often picture a rep armed with clinical data and technical knowledge, pitching the latest pharmaceutical product or medical device. But what truly sets successful reps apartespecially in multinational pharmaceutical companies (MNCs) is not just what they know, but how they connect. Soft skills, often underestimated, are the secret sauce behind thriving in this fast-paced, relationship-driven industry.
PharmaVoice
DECEMBER 2, 2024
Intrinsic Medicines is entering phase 2 trials in Parkinson’s disease and IBS for its human milk oligosaccharide drug candidates next year.
European Pharmaceutical Review
DECEMBER 2, 2024
New guidelines from the The US Pharmacopeia (USP) on mass spectrometry-based quantification of host cell protein (HCP) impurities in biologic drugs are available, as of 1 December. This follows an announcement by USP about its intent to revise General Chapter <1132.1> Residual Host Cell Protein Measurement in Biopharmaceuticals by Liquid Chromatography-Mass Spectrometry.
Expert insights. Personalized for you.
312 
Let's personalize your content